References
- Kim DS, Kim YS, Jung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7
- Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32 http://dx.doi.org/10.1183/09031936.06.00124605
- Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412
- Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative [State of the Art Series. Chronic obstructive pulmonary disease in high- and low-income countries. Edited by G. Marks and M. Chan-Yeung. Number 6 in the series]. Int J Tuberc Lung Dis 2008;12:703-8
- Briggs DD Jr. Chronic obstructive pulmonary disease overview: prevalence, pathogenesis, and treatment. J Manag Care Pharm 2004;10:S3-S10
- Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57
- Yoo KH, Kim YS, Sheen SS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65
- Korean National Statistics Office. Cause of death statistics in 2008. Daejeon: Korean National Statistic Office, 2009
- Kim JH. A cost-effectiveness analysis of long-term home oxygen therapy for patients with chronic obstructive pulmonary disease (COPD) and policy implications in Korea. Korean J Health Econ Policy 2005;11:1-38
- Korean National Health Insurance Cooperation. Health insurance statistical yearbook. Seoul: National Health Insurance Cooperation, 2008
- Chan-Yeung M, Aït-Khaled N, White N, et al. The burden and impact of COPD in Asia and Africa [State of the Art]. Int J Tuberc Lung Dis 2004;8:2-14
- Jung JY, Kang YA, Park MS, et al. Chronic obstructive lung disease related health care utilisation in Korean adults with obstructive lung disease. Int J Tuberc Lung Dis 2011;15:824-9
- World Health Organization. COPD: definition. Geneva: World Health Organization, 2015. http://www.who.int/respiratory/copd/definition/en/. Accessed June 9, 2015
- The Korean Academy of Tuberculosis and Respiratory Diseases COPD Guideline Committee. COPD guideline. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases, 2011
- Drummond MF, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes, 3rd edn. Oxford: Oxford University Press, 2005
- Kim JH, Jung JC, Kim SO. A study on individual co-payment for health insurance in Korea. Seoul: Korean National Health Insurance Cooperation, 2004
- The Korean Association for Survey Research. Weighting adjustment of the 4th KNANES (2007∼2009) and sampling design of the 5th(2010∼2012). Sejong: KNANES, 2007.
- Jung YH. Cost of illness and health-friendly fiscal policy. Health Welfare Policy Forum 2009;156:50-61
- Kim J, Kim Y. A time-cost augmented economic evaluation of oral deferasirox versus infusional deferoxamine [corrected] for patients with iron overload in South Korea. Value Health 2009;12:S78-S81
- Smith DH, Gravelle H. The practice of discounting in economic evaluations of healthcare interventions. Int J Technol Assess Health Care 2001;17:236-43
- Korean Ministry of Employment and Labor. Report on labor force survey at establishments. Sejong: Korean Ministry of Employment and Labor, 2011. http://www.moel.go.kr/english/pas/pasMOEL.jsp. Accessed June 9, 2015
- Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50
- Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004;9:458-65
- Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863-8
- Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S-9S
- Strassels SA, Smith DH, Sullivan SD, et al. The costs of treating COPD in the United States. Chest 2001;119:344-52
- Detournay B, Pribil C, Fournier M, et al. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004;7:168-74
- Darkow T, Chastek BJ, Shah H, et al. Health care costs among individuals with chronic obstructive pulmonary disease within several large, multi-state employers. J Occup Environ Med 2008;50:1130-8
- Menzin J, Boulanger L, Marton J, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med 2008;102:1248-56
- Chen YH, Yao WZ, Cai BQ, et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J (Engl) 2008;121:587-91
- Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73
- Kim SJ. Burden of disease due to COPD. Seoul: Sookmyung Women’s University, 2009. http://dcollection.lib.sookmyung.ac.kr/jsp/common/DcLoOrgPer.jsp?sItemId=000000014507. Accessed June 9, 2015
- Nielsen R, Johannessen A, Benediktsdottir B, et al. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J 2009;34:850-7